Association of Plasma C1q/TNF-Related Protein 3 (CTRP3) in Patients with Atrial Fibrillation

Table 4

Logistic regression analysis for the presence of AF.

		S.E.	OR	95% CI
Gender	-0.366	0.565	0.693	0.229-2.097	0.517
Age	0.007	0.025	1.007	0.958-1.057	0.793
BMI	-0.103	0.092	0.902	0.752-1.081	0.263
CHD	-0.672	0.678	0.511	0.135-1.928	0.322
HT	-1.045	0.553	0.352	0.119-1.039	0.059
DM	-0.752	0.663	0.471	0.129-1.727	0.256
NT-proBNP	0.004	0.002	1.004	1.000-1.007	0.042
LAD	-0.006	0.095	0.994	0.826-1.197	0.951
LAA	0.197	0.116	1.218	0.970-1.530	0.090
LVEF	-0.079	0.049	0.924	0.839-1.018	0.112
CTRP3	-0.005	0.003	0.995	0.989-1.000	0.048

BMI: body mass index; HT: hypertension; DM: diabetes mellitus; CHD: coronary heart disease; NT-proBNP: N-Terminal probrain natriuretic peptide; LAD: left atrial diameter; LAA: left atrial area; LVEF: left ventricular ejection fraction. Statistically significant at two-sided level.